Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001035704-98-000211
Filing Date
1998-03-26
Accepted
1998-03-26 00:00:00
Documents
8
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR ENDED DECEMBER 31, 1997 10-K 332383
2 1ST AMENDMENT TO LEASE EX-10.36 2282
3 1ST AMENDMENT TO LEASE EX-10.38 6472
4 CONSULTING AGREEMENT EX-10.41 4539
5 COMPUTATION OF NET LOSS PER SHARE EX-11.1 1271
6 SUBSIDIARIES OF THE REGISTRANT EX-21.1 995
7 CONSENT OF INDEPENDENT AUDITORS EX-23.1 1377
8 FINANCIAL DATA SCHEDULE EX-27.1 2264
  Complete submission text file 0001035704-98-000211.txt   353752
Mailing Address 2860 WILDERNESS PL BOULDER CO 80301
Business Address 2860 WILDERNESS PL BOULDER CO 80301 3034445893
NEXSTAR PHARMACEUTICALS INC (Filer) CIK: 0000915359 (see all company filings)

EIN.: 841173453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23012 | Film No.: 98573934
SIC: 2834 Pharmaceutical Preparations